Evidence-first guides to the peptides people actually search for — organized by what they are used for, with FDA-approval status shown on every single one.
Educational only, not medical advice.
How to read the badges
FDA approved labeled drug, real trial program
Investigational in human trials, not yet approved
Research only little or no human efficacy data
We don’t treat “peptide” as one credibility bucket
Some peptides are FDA-approved medicines with large trial programs. Others are compounds with almost no human data that happen to be popular online. Those are completely different evidence situations, so every card below carries its own status. Browsing by class helps you find a compound; the badge tells you how much to trust what you read next.
Weight, glucose, and appetite. The most clinically validated corner of the peptide world, and the reason most people find Jabbit.
Ozempic, Wegovy, Rybelsus
GLP-1 receptor agonist with a large trial program and cardiovascular outcomes data.
Mounjaro, Zepbound
Dual GLP-1/GIP agonist approved for type 2 diabetes and chronic weight management.
“Triple G” agonist
GLP-1/GIP/glucagon agonist in Phase 3 trials — promising, but not yet approved.
EGRIFTA · narrow indication
GHRH analog approved specifically for HIV-associated lipodystrophy, not general fat loss.
Tissue, tendon, and gut repair. Heavily discussed in sport and recovery circles, but the human evidence is thin.
Compounds that nudge the body’s own growth-hormone axis. Real pharmacology, but abandoned or never completed as approved drugs.
Nootropic and anxiolytic peptides developed and used in Russia, but never reviewed by the FDA or EMA.
Anti-aging and cosmetic peptides. Interesting biology and big claims — the claims usually run well ahead of the human data.
For approved drugs
Start with the FDA label, pivotal trial publications, and official safety communications.
For research compounds
Ask whether the literature is animal-only, uncontrolled, early-stage, or absent in humans.
For regulatory context
Use enforcement letters, shortage notices, and formal policy updates instead of vendor claims.
Jabbit is a private tracker for injections and protocols — it logs what you take, when, and how you respond, whether that’s a prescribed GLP-1 or something you’re researching. The editorial standard here matches the app: help people understand labels, evidence, and uncertainty without turning the category into marketing theater.